LORAZ TAB

Each film coated tablet contains: Losartan potassium 50 mg and Hydrochlorothiazide 12.5 mg.

24.00 EGP

Purchase this product now and earn 24 Points!

LORAZ TAB; losartan, hydrochlorothiazide, cardiovascular agents .

ACTIVE-INGREDIENT OF LORAZ TAB

Each film coated tablet contains: Losartan potassium 50 mg and Hydrochlorothiazide 12.5 mg.

INDICATION OF LORAZ TAB

Hypertension: Loraz is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial therapy of hypertension, except when the hypertension is severe enough that the value of achieving prompt blood pressure control exceeds the risk of initiating combination therapy in theses patients. Hypersensitive patients with left ventricular hypertrophy: Loraz is indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy but there is evidence that this benefit does not apply to Black patients.

DOSAGE OF LORAZ TAB

Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet

Ask your pharmacist or doctor for help if you do not understand the instructions on the box .

The recommended dose is : –

Dosage and administration: Loraz can be taken before, during and after meals. The usual starting and maintenance dosage is one tablet of Loraz once daily. If necessary, the dosage may be increased to a maximum of two tablets of Loraz DAILY. The dosage however should be individualized. If patient will be treated with Loraz after monotherapy with a diuretic drug, the diuretic should be stopped 2-3 day before beginning treatment of Loraz. No initial dosage adjustment is necessary for elderly patients.

OVER-DOSAGE OF LORAZ TAB

No specific information is available on the treatment of overdosage with losartan / hydrochlorothiazide . Treatment is symptomatic and supportive . Therapy with loraz should be discontinued and the patient observed closely .suggested measures include induction of emesis if ingestion is recent , and correction of dehydration , electrolyte imbalance , hepatic coma and hypertention by established procedures . losartan potassium : limited data are available in regard to overdosage in humans . the most likely manifestation of overdosage would be hypotention and tachycardia ; bradycardia could occur from parasympathetic (vagal ) stimulation . if symptomatic hypertention should ocur , supportive treatment should be insittuted . neither losartan nor the active metabolite can be removed by hemodialysis . hydrochlorothiazide : the most common signs and symptoms observed are those caused by electrolyte depletion ( hypokalemia , hypochloremia , hyponatremia ) and dyhydration resulting from excessive diuresis . if digitalis has also been administered , hypokalemia may accentuate cardiac arrhythmias . the degree to which hydrochlorothiazide is removed by hemodialysis has not been established .

CONTRA-INDICATION OF LORAZ TAB

Patients who are hypersensitive to any component of this product. Patients who are hypersensitive to other sulfonamide-derived drugs. Patients with anuria. The concomitant use of Loraz with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (GFR STORAGE OF LORAZ TAB

Storage at temperature no to exceeding 30 ° C , in a dry place , Keep out of reach of children.
PACK OF LORAZ TAB
Carton box containing 2 (Al/PVC) strips each strip contains 7 film coated tablets, with inner leaflet.
LORAZ TAB MANUFACTURED BY
Egyptian Group for Pharmaceutical Industries.

https://www.medicines.org.uk/emc/product/7799/smpc

https://www.gardeniapharmacy.com/category/medicine-2/

Form

Gender

How to use

Reviews

There are no reviews yet.

Show reviews in all languages (1)

Be the first to review “LORAZ TAB”

Your email address will not be published.

Shopping Cart
Don`t copy text!
Scroll to Top